U.S. Agrees To Buy 100 Million Doses Of Another COVID-19 Vaccine

Moderna plans to purchase 100 million doses of its experimental COVID-19 vaccine, developed with the National Institutes of Health, which is in late-stage trials. Unlike traditional vaccines, Moderna's uses mRNA to trigger an immune response. The U.S. government has a $1.5 billion contract with Moderna, allowing for the purchase of up to 400 million additional doses. Moderna is manufacturing the vaccine to ensure quick distribution upon approval. The Trump administration has similar deals with other companies, aiming for a vaccine by the end of 2020.

What new insight or understanding did you gain from this video?